Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil IV PCA for VT Ablation
NCT01901575Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 2011
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in ventricular tachycardia (VT), premature ventricular contraction (PVC), sponsored by NYU Langone Health. Started Jul 2011; status: completed.
02
Drugs
remifentanil
03
Conditions
ventricular tachycardia (VT)premature ventricular contraction (PVC)
Beyond the preview
Go deeper on NCT01901575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01901575.